[Brain functional imaging in Alzheimer's disease].
Alzheimer's disease is nowadays the leading cause of dementia. It affects more than a third of people over 85 years old. The gold standard diagnostic proof is currently based upon pathology examination. It seems rather crucial to find methodologies that make an early and accurate in vivo diagnosis so as to offer the patient the most suitable treatment. We hereby go over several available neuro-imaging techniques used in nuclear medicine that increase the diagnostic accuracy of Alzheimer's disease.
Ravasi
Laura
L
Service de médecine nucléaire et d'imagerie fonctionnelle, EA 1049, Hôpital Roger Salengro, CHU, Université de Lille Nord de France. laura.ravasi@chru-lille.fr
Semah
Franck
F
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000503:physiopathology* / Q000523:psychology; D000686:Amyloidosis / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000503:physiopathology / Q000523:psychology; D001921:Brain / Q000098:blood supply / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D002540:Cerebral Cortex / Q000098:blood supply / Q000000981:diagnostic imaging / Q000503:physiopathology; D003430:Cross-Sectional Studies; D003937:Diagnosis, Differential; D004292:Dominance, Cerebral / Q000502:physiology; D004298:Dopamine / Q000378:metabolism; D004734:Energy Metabolism / Q000502:physiology; D057180:Frontotemporal Dementia / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000503:physiopathology / Q000523:psychology; D006801:Humans; D020961:Lewy Body Disease / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000503:physiopathology / Q000523:psychology; D049268:Positron-Emission Tomography; D012039:Regional Blood Flow / Q000502:physiology; D015899:Tomography, Emission-Computed, Single-Photon
D004298:Dopamine